John A. H. Wass

John A. H. Wass's AcademicInfluence.com Rankings

John A. H. Wass

Philosophy

#4752

World Rank

#7381

Historical Rank

Logic

#2145

World Rank

#3070

Historical Rank

philosophy Degrees

John A. H. Wass

Biology

#6272

World Rank

#8948

Historical Rank

Endocrinology

#57

World Rank

#67

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is John A. H. Wass Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John A. H. Wass's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. (2011) (1237)
Acromegaly: an endocrine society clinical practice guideline. (2014) (1237)
Criteria for cure of acromegaly: a consensus statement. (2000) (1006)
Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) (2010) (822)
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas (2006) (679)
Classical pituitary apoplexy: clinical features, management and outcome (1999) (515)
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up (2005) (485)
Characterization of mutations in patients with multiple endocrine neoplasia type 1. (1998) (426)
Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. (2000) (392)
Turner's syndrome in adulthood. (2002) (387)
Guidelines for acromegaly management. (2002) (338)
UK guidelines for the management of pituitary apoplexy (2011) (328)
A Consensus Statement on acromegaly therapeutic outcomes (2018) (325)
Obesity and polycystic ovary syndrome (2006) (306)
The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. (2011) (298)
A consensus on the diagnosis and treatment of acromegaly complications (2012) (289)
Angiogenesis in endocrine tumors. (2003) (283)
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. (2008) (278)
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. (2002) (272)
Metabolic characteristics of women with polycystic ovaries and oligo‐amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome (2007) (241)
Consensus statement: medical management of acromegaly. (2005) (227)
Long-term treatment of acromegaly with bromocriptine. (1977) (227)
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome (1995) (226)
Acromegaly, colonic polyps and carcinoma (1997) (222)
The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. (1991) (218)
ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN? (1988) (203)
Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure (1996) (201)
Undetectable postoperative cortisol does not always predict long‐term remission in Cushing’s disease: a single centre audit * (2002) (198)
Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. (1989) (191)
Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. (2006) (190)
Metabolic syndrome in polycystic ovary syndrome. (2007) (189)
Epidemiology of acromegaly: review of population studies (2016) (185)
Angiogenesis in pituitary adenomas and the normal pituitary gland. (2000) (171)
An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year (1994) (171)
Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome (2001) (171)
Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary macroadenoma (2006) (171)
Oxford Handbook of Endocrinology and Diabetes (2002) (169)
Association of the TSHR gene with Graves' disease: the first disease specific locus (2005) (168)
REDUCTION OF PITUITARY-TUMOUR SIZE IN PATIENTS WITH PROLACTINOMAS AND ACROMEGALY TREATED WITH BROMOCRIPTINE WITH OR WITHOUT RADIOTHERAPY (1979) (162)
Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. (2008) (160)
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update. (2020) (151)
CORTICOTROPHIN RELEASING FACTOR: RESPONSES IN NORMAL SUBJECTS AND PATIENTS WITH DISORDERS OF THE HYPOTHALAMUS AND PITUITARY (1984) (148)
Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. (2005) (145)
Genetic Analyses in a Sample of Individuals With High or Low BMD Shows Association With Multiple Wnt Pathway Genes (2007) (145)
EFFECTS OF LUTEINIZING HORMONE, INSULIN, INSULIN‐LIKE GROWTH FACTOR‐I AND INSULINLIKE GROWTH FACTOR SMALL BINDING PROTEIN 1 IN THE POLYCYSTIC OVARY SYNDROME (1990) (144)
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status (2011) (144)
Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas (2018) (143)
Suggestive Linkage of the Parathyroid Receptor Type 1 to Osteoporosis (1999) (143)
THE GROWTH HORMONE INDEPENDENT INSULIN‐LIKE GROWTH FACTOR‐I BINDING PROTEIN BP‐28 IS ASSOCIATED WITH SERUM INSULIN‐LIKE GROWTH FACTOR‐I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN‐DEPENDENT DIABETICS (1990) (142)
What is the natural history of nonoperated nonfunctioning pituitary adenomas? (2007) (139)
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone (2010) (138)
Influence of LRP5 Polymorphisms on Normal Variation in BMD (2004) (138)
Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. (2009) (129)
Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. (2012) (127)
Non‐functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently (2003) (126)
Cytokine gene polymorphisms in autoimmune thyroid disease. (2000) (124)
Rathke’s cleft cysts (2012) (123)
Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. (2016) (121)
The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome. (1995) (121)
Diagnosis and treatment of acromegaly complications (2003) (117)
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. (2000) (117)
The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. (1992) (115)
Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome (2008) (115)
Multidisciplinary management of acromegaly: A consensus (2020) (112)
Molecular Scanning of the Insulin Receptor Gene in Syndromes of Insulin Resistance (1994) (112)
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. (1983) (111)
What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics. (2007) (105)
Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome. (2009) (104)
Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. (2000) (104)
RELATIONSHIP BETWEEN THE PUBERTAL FALL INSEX HORMONE BINDING GLOBULIN AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN‐I. A SYNCHRONIZED APPROACH TO PUBERTAL DEVELOPMENT? (1989) (103)
Hormone replacement therapy may improve hepatic function in women with Turner's syndrome (2001) (103)
Autoimmune thyroid syndrome in women with Turner's syndrome--the association with karyotype. (2001) (102)
Psychotic reactions during treatment of pituitary tumours with dopamine agonists. (1984) (102)
Site and Gender Specificity of Inheritance of Bone Mineral Density (2003) (101)
Valvular heart disease and the use of cabergoline for the treatment of prolactinoma (2009) (101)
GH replacement does not increase the risk of recurrence in patients with craniopharyngioma (2006) (99)
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas. (2013) (98)
Bromocriptine in management of large pituitary tumours. (1982) (97)
Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. (2004) (93)
Antiangiogenic effects of somatostatin analogues (2002) (93)
Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. (1993) (93)
Imaging islet cell tumours. (1994) (93)
Role of matrix metalloproteinase 9 in pituitary tumor behavior. (2000) (92)
Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects (1981) (91)
GROWTH-HORMONE-RELEASING FACTOR IN GROWTH HORMONE DEFICIENCY: DEMONSTRATION OF A HYPOTHALAMIC DEFECT IN GROWTH HORMONE RELEASE (1983) (90)
The cortisol stress response induced by surgery: A systematic review and meta‐analysis (2018) (88)
Autoimmune thyroid syndrome in women with Turner's syndrome—the association with karyotype (2001) (87)
CIRCULATING SOMATOSTATIN AFTER FOOD AND GLUCOSE IN MAN (1980) (87)
Axonal Transport of Neuropeptides in the Cervical Vagus Nerve of the Rat (1980) (86)
Gallstones during octreotide therapy. (1992) (86)
Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour (2000) (85)
The effect of the menopause on prolactin levels in patients with hyperprolactinaemia (2001) (85)
Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? (2010) (85)
Megavoltage pituitary irradiation in the management of prolactinomas: long‐term follow‐up (1991) (85)
CHANGES IN CIRCULATING SOMATOMEDIN‐C LEVELS IN BROMOCRIPTINE‐TREATED ACROMEGALY (1982) (84)
Inhibition of interleukin 2 production by factors released from tumor cells. (1983) (84)
A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. (2006) (83)
The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. (2000) (83)
Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease (2001) (83)
Management of endocrine disease: pituitary tumour apoplexy. (2015) (83)
An account of the quality of life of patients after treatment for non‐functioning pituitary tumours (1997) (82)
High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. (1984) (81)
Wide variation in surgical outcomes for acromegaly in the UK (2008) (81)
60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly. (2015) (79)
Parathyroid adenomas and cardiovascular risk. (2003) (78)
Whole-exome sequencing studies of nonfunctioning pituitary adenomas. (2013) (77)
Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists (2013) (76)
The chemotactic response of tumor cells. A model for cancer metastasis. (1981) (76)
Pituitary tumours in the elderly: a 20 year experience. (1999) (75)
The role of growth hormone in diabetes mellitus. (1988) (75)
Impact of musculoskeletal disease on quality of life in long-standing acromegaly. (2008) (75)
The Pathology of Median Neuropathy in Acromegaly (2000) (75)
Opioid induced hypogonadism (2010) (74)
The regulation of insulin‐like growth factor binding protein (IGFBP)‐1 during prolonged fasting (1993) (73)
A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo‐pituitary‐adrenal axis in the early post‐operative period after hypophysectomy (1997) (73)
Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones (1999) (72)
DECREASED SEX HORMONE BINDING GLOBULIN (SHBG) AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP‐1) IN EXTREME OBESITY (1990) (72)
AUTOIMMUNE CRANIAL DIABETES INSIPIDUS: ITS ASSOCIATION WITH OTHER ENDOCRINE DISEASES AND WITH HISTIOCYTOSIS X (1986) (72)
Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? (1999) (70)
Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones. (1996) (69)
Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines (2010) (69)
Assessment of p27 (cyclin‐dependent kinase inhibitor 1B) and aryl hydrocarbon receptor‐interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations (2009) (68)
Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism. (1996) (68)
Hypopituitarism following envenoming by Russell's vipers (Daboia siamensis and D. russelii) resembling Sheehan's syndrome: first case report from Sri Lanka, a review of the literature and recommendations for endocrine management. (2011) (68)
Clinical Endocrine Oncology (1997) (66)
Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. (1984) (65)
Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers (2017) (64)
Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach. (2006) (64)
Growth of three established cell lines on glass microcarriers (1983) (64)
StatXact 4 for Windows (2000) (64)
The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. (1994) (63)
Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours? (1999) (63)
Investigation protocol: Acromegaly and its investigation (1999) (62)
Oncological Complications of Excess GH in Acromegaly (2004) (61)
Pituitary imaging using a labelled somatostatin analogue in acromegaly (1992) (60)
AN ASSESSMENT OF GLUCOSE INTOLERANCE IN ACROMEGALY AND ITS RESPONSE TO MEDICAL TREATMENT (1980) (60)
The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. (1989) (60)
Pituitary apoplexy in non‐functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences (2011) (58)
The value of an acute octreotide suppression test in predicting long‐term responses to depot somatostatin analogues in patients with active acromegaly (2005) (58)
Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly. (1993) (58)
The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism. (1992) (57)
Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. (2001) (57)
Action on obesity: comprehensive care for all. (2013) (57)
Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery (2020) (56)
How to avoid precipitating an acute adrenal crisis (2012) (56)
Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. (2007) (56)
Heat-shock gene expression and cell cycle changes during mammalian embryonic development. (1993) (56)
THE EFFECT OF DOPAMINE AGONIST THERAPY ON LARGE FUNCTIONLESS PITUITARY TUMOURS (1985) (56)
Malignant prolactinoma with extracranial metastases: a report of three cases (1993) (55)
PROLACTINOMAS PRESENTING AS PRIMARY AMENORRHOEA AND DELAYED OR ARRESTED PUBERTY: RESPONSE TO MEDICAL THERAPY (1989) (53)
‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass (2011) (52)
Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly (2005) (50)
Diagnostic and therapeutic review of cystic parathyroid lesions (2012) (50)
A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. (2013) (49)
Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins. (2000) (49)
Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome. (2008) (49)
INSULIN‐LIKE GROWTH FACTOR BINDING PROTEINS IN FOLLICULAR FLUID FROM NORMAL DOMINANT AND COHORT FOLLICLES, POLYCYSTIC AND MULTICYSTIC OVARIES (1990) (48)
Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma (2011) (48)
Role of intestinal transit in the pathogenesis of gallbladder stones. (1997) (48)
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists (2011) (47)
Bombesin-like immunoreactivity in human gastrointestinal tract (1984) (47)
Systematic dose‐extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly (2004) (47)
Insulin‐like Growth Factor Binding Protein‐1 Levels in Diabetic Adolescents and their Relationship to Metabolic Control (1990) (47)
Cyclic prednisolone therapy for male infertility associated with autoantibodies to spermatozoa. (1986) (47)
Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man. (1978) (46)
Pituitary surgery for acromegaly (1999) (46)
Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up. (2015) (46)
Lymphocytic hypophysitis: unusual features of a rare disorder (1995) (46)
A tale of pituitary adenomas: to NET or not to NET (2019) (46)
Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. (2008) (45)
Asymptomatic hyperparathyroidism – need for multicentre studies (2007) (45)
Radiation-induced hypopituitarism. (2009) (45)
Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN. (2017) (45)
Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. (1984) (43)
Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia (2019) (43)
Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes. (1993) (42)
Chlorpropamide alcohol flush and circulating met-enkephalin: a positive link. (1981) (41)
MOLECULAR FORMS OF SOMATOSTATIN IN NORMAL SUBJECTS AND IN PATIENTS WITH PANCREATIC SOMATOSTATINOMA (1980) (41)
Gender- and age-related differences in osteoclast formation from circulating precursors. (2002) (41)
Reversible respiratory muscle weakness in hyperthyroidism. (1989) (40)
Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging (2010) (39)
The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia. (1991) (38)
GH replacement in patients with non‐functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence (2009) (38)
Current treatment protocols can offer a normal or near‐normal quality of life in the majority of patients with non‐functioning pituitary adenomas (2013) (37)
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. (2008) (37)
Worse Health‐Related Quality of Life at long‐term follow‐up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN (2018) (37)
Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS (2007) (36)
DEPOT‐BROMOCRIPTINE TREATMENT FOR PROLACTINOMAS AND ACROMEGALY (1986) (36)
COMPARISON OF THE CLINICAL ACTIVITY OF MESULERGINE AND PERGOLIDE IN THE TREATMENT OF HYPERPROLACTINAEMIA (1985) (36)
Angiogenesis in Prolactinomas: Regulation and Relationship with Tumour Behaviour (2005) (35)
Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, 123 I‐Try3‐octreotide and 111in‐pentatreitide (1993) (35)
Diagnosis and management of prolactinomas and non-functioning pituitary adenomas (2014) (35)
Increased insulin sensitivity in young, growth hormone deficient children (2001) (35)
Radiotherapy in acromegaly: a protagonists viewpoint (2003) (35)
Guidance for the prevention and emergency management of adult patients with adrenal insufficiency. (2020) (34)
Medical problems in adult women with Turner's syndrome. (1999) (34)
The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults. (2002) (34)
IMMUNOREACTIVE SOMATOSTATIN CHANGES DURING INSULIN‐INDUCED HYPOGLYCAEMIA AND OPERATIVE STRESS IN MAN (1980) (34)
Osteoclast formation from circulating precursors in osteoporosis (2003) (33)
Acromegaly--results of long term treatment with bromocriptine. (1978) (33)
Renal failure, glomerular disease and diabetes mellitus. (1978) (33)
THE EFFECT OF LISURIDE HYDROGEN MALEATE, AN ERGOT DERIVATIVE ON ANTERIOR PITUITARY HORMONE SECRETION IN MAN (1979) (33)
FAMILIAL ACROMEGALY: STUDIES IN THREE FAMILIES (1990) (33)
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia (2020) (32)
The presence of cation‐dependent proteases for insulin‐like growth factor binding proteins does not alter the size distribution of insulin‐like growth factors in pregnancy (1991) (32)
Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly. (1997) (32)
Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease (2004) (32)
SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients (2016) (31)
Nonfunctioning pituitary adenomas: the Oxford experience (2009) (31)
SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus (2018) (31)
Growth hormone neuroregulation and the clinical relevance of somatostatin. (1983) (31)
Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions. (2004) (30)
SOMATOSTATIN SECRETION BY LUNG AND THYMIC TUMOURS (1980) (30)
Suppression of endogenous insulin secretion regulates the rapid rise of insulin‐like growth factor binding protein (IGFBP)‐1 levels following acute hypoglycaemia (1993) (30)
Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. (2018) (29)
RISK FACTOR FOR MYOCARDIAL INFARCTION IN TRANSURETHRAL RESECTION OF PROSTATE? (1989) (29)
Gall stones and treatment with octreotide for acromegaly (1989) (29)
Pituitary, adrenal and thyroid incidentalomas (1998) (29)
Clinical Biology of the Pituitary Adenoma (2022) (28)
Respiratory muscle strength in Cushing's syndrome. (1999) (28)
Non-adenomatous pituitary tumours. (2009) (28)
Gallstones during octreotide therapy. (1993) (28)
Insulin-like growth factor binding proteins (IGFBPs) in acromegaly. (1991) (28)
Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors (2020) (27)
Digital Vasospasm with Bromocriptine (1976) (26)
EFFECTS OF THE H2 RECEPTOR ANTAGONIST CIMETIDINE ON PITUITARY HORMONES IN MAN (1979) (26)
The postoperative monitoring of nonfunctioning pituitary adenomas (2011) (25)
Characteristics of the chemotactic factor-mediated cell swelling response of tumor cells. (1981) (25)
Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. (1991) (25)
Growth hormone in the treatment of dilated cardiomyopathy. (1996) (24)
Pituitary Tumours: Recommendations for Service Provision and Guidelines for Management of Patients (1998) (24)
Intestinal control of gastric function in the calf: the relationship of neural and endocrine factors (1981) (24)
Lipids and coronary heart disease (2001) (24)
PTHR1 Polymorphisms Influence BMD Variation through Effects on the Growing Skeleton (2007) (24)
Adrenocorticotrophin‐independent unilateral macronodular adrenal hyperplasia occurring with myelolipoma: an unusual cause of Cushing's syndrome (1994) (24)
Ultrasound-guided percutaneous fine needle puncture of the gallbladder for studies of bile composition. (1995) (23)
A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy (2007) (23)
Growth hormone and memory. (2010) (23)
Intracardiac metastases from neuroendocrine tumours (1997) (23)
Actin changes in normal human and rat leukocytes and in transformed human leukocytic cells. (1983) (23)
The Importance of Locating a Good Pituitary Surgeon (1999) (22)
Effect of cyclosporin A in male autoimmune infertility. (1986) (22)
Octreotide treatment of acromegaly. (1990) (22)
Pituitary disorders in pregnancy (2015) (22)
Sex Hormone Binding Globulin Levels in Adolescent Subjects with Diabetes Mellitus (1992) (22)
CSF AND PLASMA SOMATOSTATIN LEVELS IN ACROMEGALY (1980) (22)
Acromegaly: treatment after 100 years. (1993) (22)
Absence of uterine neoplasia in patients on bromocriptine. (1977) (22)
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline? (2013) (21)
Bromocriptine in the medical management of acromegaly. (1980) (21)
Characterization of the molecular genetic pathology in patients with 11β‐hydroxylase deficiency (2015) (21)
Calcium and bone metabolism (2014) (21)
CONSENSUS Guidelines for Acromegaly Management (2002) (20)
Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly. (1999) (20)
IMMUNOREACTIVE HUMAN CHORIONIC GONADOTROPHIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA (1988) (19)
Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid. (1995) (19)
11 The treatment of acromegaly (1986) (19)
Effects of Luteinizing Hormone, Insulin, Insulin-like Growth Factor4 and Insulin-like Growth Factor Small Binding Protein 1 in the Polycystic Ovary Syndrome (1991) (19)
SUCCESSFUL TREATMENT BY CHEMOTHERAPY FOR ACROMEGALY ASSOCIATED WITH ECTOPIC GROWTH HORMONE RELEASING HORMONE SECRETION FROM A CARCINOID TUMOUR (1990) (18)
Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide. (1981) (18)
Pituitary tumours in the elderly. (1997) (18)
Circulating immunoreactive somatostatin in man. Effect of age, pregnancy, growth hormone deficiency and achlorhydria. (1985) (18)
An objective scoring tool in the management of patients with pituitary apoplexy (2011) (18)
Long-term effects of radiotherapy for acromegaly on circulating prolactin. (1989) (17)
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? (2021) (17)
Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels (2007) (16)
Endocrinology in the time of COVID-19: Management of Hyponatraemia and Diabetes Insipidus. (2020) (16)
The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine. (1987) (15)
Chemotactic factor-induced adherence of tumor cells. (1981) (15)
Thyroid Screening During Early Pregnancy and the Need for Trimester Specific Reference Ranges: A Cross-Sectional Study in Lahore, Pakistan (2019) (15)
A comparison of the calving behaviour of farmed adult and yearling red deer (Cervus elaphus) hinds (2003) (15)
Renal excretion of fluoride in renal failure and after renal transplantation. (1975) (15)
Modern approaches to treating acromegaly. (2000) (15)
When to discontinue treatment of prolactinoma? (2006) (15)
Size increase induced in Walker ascites cells by chemotactic factors. (1980) (15)
hCGβ PRODUCING PINEAL CHORIOCARCINOMA (1982) (15)
HYPERPROLACTINAEMIA AND MICROADENOMAS IN PRIMARY HYPOTHYROIDISM (1987) (14)
Debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogues. (2005) (14)
Evidence for the effectiveness of radiotherapy in the treatment of acromegaly. (1997) (14)
Males with prolactinoma are at increased risk of incident cardiovascular disease (2018) (14)
Two site-specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor-binding protein-3 in the circulation. (1993) (14)
Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide. (2012) (14)
Somatostatin octapeptide (SMS 201-995) in the medical treatment of acromegaly. (1986) (14)
The tale in evolution: clarity, consistency and consultation, not contradiction and confusion (2020) (14)
Nelson syndrome: definition and management. (2014) (13)
COMPARISON OF LONG‐ACTING ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN MAN (1979) (13)
Effects of low dose oral triiodothyronine in myxoedema coma (2004) (13)
Bromocriptine in acromegaly. (1981) (13)
Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe. (2014) (13)
Splanchnic and Hepatic Metabolism of Somatostatin: A Study in Cirrhotic Patients with a Portacaval Shunt (2007) (13)
Correlation of endogenous somatostatin, gastric inhibitory polypeptide, glucagon and insulin with gastric function in the conscious calf. (1981) (13)
Craniopharyngiomas. Historical aspects of their management (2008) (13)
First Steps in Experimental Design— The Screening Experiment (2010) (12)
Circulating levels of placental protein 12 and chorionic gonadotrophin following RU 38486 and gemeprost for termination of first trimester pregnancy. (1989) (12)
Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormone. (1983) (12)
Slow intestinal transit and gallstone formation (1993) (12)
Nurturing tomorrow's clinician scientists (2013) (11)
Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas. (2004) (11)
PLEUROPULMONARY SHADOWS ON BROMOCRIPTINE (1981) (11)
Long-term effects of radiotherapy for acromegaly. (1996) (11)
The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly (2009) (11)
Origin 7.0 (2002) (11)
UK guidelines for the management of pituitary apoplexy a rare but potentially fatal medical emergency (2010) (11)
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia (2021) (11)
Absence of mutations in the MEN2A region of the ret proto‐oncogene in non‐MEN 2A phaeochromocytomas (1995) (11)
Prevalence of gastritis in patients with acromegaly: untreated and during treatment with octreotide (1992) (11)
Respiratory muscle weakness in Addison's disease. (1988) (10)
The medical management of hormone-secreting tumors of the pituitary. (1983) (10)
Late Effects of Cancer Treatment (2017) (10)
Proceedings of the discussion, "Tolerability and safety of Sandostatin". (1992) (9)
Insulin-like growth factors; autocrine, paracrine or endocrine? (1989) (9)
Characterisation by high performance liquid chromatography of circulating growth hormone releasing factors in a human plasma. (1985) (9)
Acromegaly or chronic renal failure: a diagnostic dilemma (1997) (9)
Pituitary adenomas (2019) (9)
Gene deletion causing adrenal hypoplasia congenita and hypogonadotrophic hypogonadism (1994) (9)
Liothyronine cost and prescriptions in England. (2019) (9)
Modeling Molecules (2000) (9)
Dynamic testing in the diagnosis and follow-up of patients with acromegaly. (2003) (8)
Methoxyflurane anesthesia for Rana pipiens. (1974) (8)
Royal College of Physicians’ flagship conference (2013) (8)
Observations on the hiding behaviour of farmed red deer (Cervus elaphus) calves (2004) (8)
Volume-outcome relationship for adrenalectomy: analysis of an administrative dataset for the Getting It Right First Time Programme. (2021) (8)
Proceedings of the discussion: 'Tolerability and safety of Sandostatin'. (1993) (8)
Growth hormone (GH) replacement therapy in adults (2009) (8)
Pituitary tumours: recommendations for service provision and guidelines for management of patients. Royal College of Physicians. (1998) (8)
Medical Management of Acromegaly with Bromocriptine Effects of Continuous Treatment for Over Three Years (1978) (7)
The Therapeutic Value of Somatostatin and Its Analogues (1999) (7)
The development and characterization of an eluted stain assay (ESTA) for the insulin-like growth factors. (1993) (7)
Pituitary Tumors in the Elderly: A 20 Year Experience (1999) (7)
Second brain tumour after treatment for pituitary adenoma. (1992) (7)
Volume-Outcome Associations for Parathyroid Surgery in England: Analysis of an Administrative Data Set for the Getting It Right First Time Program. (2022) (7)
13.4 Management of diabetes mellitus (2011) (7)
Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation? (2007) (7)
Nutrient sensitivity of gastric emptying of digesta in the preruminant calf (1988) (6)
Quantitative Bacteriology of the Seminal Fluid in Health and Disease (1990) (6)
Hypopituitarism: growth hormone and corticotropin deficiency. (2015) (6)
The enhanced peroxidase one step method increases sensitivity for detection of Ki-67 in pituitary tumours. (1999) (6)
Pituitary tumour apoplexy (2015) (6)
Octreotide increases the proportions of arachidonic acid‐rich phospholipids in gall‐bladder bile (2001) (6)
Ketamine-methoxyflurane anesthesia for rabbits. (1974) (5)
Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotide (1995) (5)
Characterization by high-performance liquid chromatography of circulating growth hormone-releasing factors in normal subjects. (1986) (5)
Hypoparathyroidism and coeliac disease: a potentially dangerous combination (2009) (5)
Clinical presentation of Cushing's syndrome in a large series from the European Registry on Cushing's syndrome (ERCUSYN) (2011) (5)
ARE THERE GENETIC DETERMINANTS FOR THE GLUCOSE INTOLERANCE OF ACROMEGALY? (1985) (5)
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. (2022) (5)
Clinical Neuroendocrine Relationships in Normal and Disordered Prolactin Secretion (1979) (5)
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. (2022) (4)
Hypothalamic Regulating Hormones (1983) (4)
State-of-the-art strategies for the diagnosis and management of acromegaly (2001) (4)
Somatostatin Octapeptide (SMS 201–995, Sandostatin®) in the Medical Treatment of Acromegaly (1988) (4)
An e-mail GP advisory service: a more efficient way of dealing with clinical enquiries. (2009) (4)
The role of AIP in familial acromegaly (2007) (4)
The effect of a prostaglandin (PG) agonist and antagonist on postprandial plasma somatostatin and gastrin in man (1984) (4)
HYPOTHALAMIC-PITUITARY EFFECTS OF CIMETIDINE (1978) (4)
Short report: plasma somatostatin concentrations in the irritable bowel syndrome (1991) (3)
The pharmacology of post prandial somatostatin release in man (1983) (3)
New Treatments for Acromegaly (1998) (3)
CHRONIC OCTREOTIDE TREATMENT OF ACROMEGALY INDUCES CHANGES IN GALLBLADDER BILE COMPOSITION WHICH PREDISPOSE TO GALLSTONES (1993) (3)
Comprar Oxford Textbook of Endocrinology and Diabetes 2Ed | Melanie C. Davies | 9780199235292 | Oxford University Press (2011) (3)
Investigation of bone (2009) (3)
An unusual cause of pancytopaenia. (2007) (3)
A Further Step in Experimental Design (III): The Response Surface (2011) (3)
Steroid-dependent patients with multiple co-morbidities are more vulnerable to adrenal crisis (2015) (3)
Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery in adrenal insufficiency (2020) (3)
Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2018) (3)
The fantastical world of hormones (2017) (3)
Outcome of non-functioning pituitary adenomas that regrow after primary treatment: a study from two large specialist UK centers (2017) (3)
Bromocriptine and endocrine disorders. (1979) (3)
hCG beta producing pineal choriocarcinoma. (1982) (3)
150th anniversary of the RMBF (Royal Medical Benevolent Fund). (1986) (3)
Insulin induced somatostatin secretion in man is mediated by gastric acid (1983) (3)
Letter: Digital vasospasm with bromocriptine. (1976) (2)
Measurement of somatostatin. (1988) (2)
Bromocriptine in management of large pituitary tumours. (1982) (2)
Treatment of pituitary tumors (2005) (2)
Partitioning of Cholesterol (CH) between Vesicular and Micellar Phases of Gallbladder (GB) Bile Obtained by Percutaneous Fine Needle Aspiration (1992) (2)
Disorders of the anterior pituitary gland (2010) (2)
Congenital adrenal hyperplasia (CAH) in adults (2009) (2)
Roles of colonic transit, bacteriology, bile acid metabolizing enzymes and deoxycholic acid in the pathogenesis of gallstones and colorectal cancer in acromegalic patients before and during octreotide treatment (1998) (2)
Consider Addison’s disease in differential diagnosis of eating disorders in children and young people (2018) (2)
Lymphoplasmacytoid lymphoma presenting as severe osteoporosis (2002) (2)
The future of endocrinology in Europe--a view from across La Manche on connection to the mainland. (1996) (2)
Humoral factors influencing osteoclast differentiation from circulating mononuclear precursors in Paget's disease. (1999) (2)
Late diagnosis of pituitary and parapituitary lesions causing visual failure. (1986) (2)
Duodenal factors controlling somatostatin secretion in man (1980) (2)
Faculty Opinions recommendation of Determinants of skeletal loss and recovery in anorexia nervosa. (2006) (2)
Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro (2011) (2)
External Radiation Therapy of Acromegaly (1988) (2)
Treatment of prolactinomas with megavoltage radiotherapy. (1984) (2)
DOPAMINE AND INHIBITION OF PROLACTIN AND GROWTH-HORMONE SECRETION (1976) (2)
Association of variants within the fat mass and obesity-associated (FTO) gene and polycystic ovary syndrome (2008) (2)
How to do a water deprivation test: interpretation of results (2008) (2)
THE GROWTH HORMONE RELEASING HORMONE (GHRH) RESPONSE TO A MIXED MEAL IS BLUNTED IN YOUNG ADULTS WITH INSULIN‐DEPENDENT DIABETES MELLITUS WHEREAS THE SOMATOSTATIN RESPONSE IS NORMAL (1990) (2)
Comprar Oxford Handbook of Endocrinology and Diabetes 2ed | John Wass | 9780198567394 | Oxford University Press (2009) (2)
The Use of Dopamine Agonists in the Management of Acromegaly (1987) (2)
Somatostatin Octapeptide in the Medical Treatment of Acromegaly (1987) (1)
BISPHOSPHONATE TREATMENT OF GIANT CELL TUMOUR OF BONE (2011) (1)
Combined oral contraceptive pill (COCP) (2009) (1)
The European Registry on Cushing's syndrome (ERCUSYN) database: first year experience (2010) (1)
Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly (2010) (1)
Octreotide treatment of acromegaly. Discussion (1990) (1)
High prevalence of pituitary adenomas: a cross-sectional study in the city of Banbury (Oxfordshire) (2008) (1)
What is the final outcome in patients with macroprolactinoma resistant to dopamine agonists (2005) (1)
Adrenal emergencies in treated addisons disease (2007) (1)
Endocrinology and ageing (2009) (1)
The changing patterns of presentation and treatment of acromegaly in the UK as reflected by the UK National Acromegaly Database (2004) (1)
Increased infection risk in Addison’s disease and congenital adrenal hyperplasia: a primary care database cohort study (2019) (1)
Prevention of adrenal crisis in stress (The PACS Study): serum cortisol during elective surgery, acute trauma and sepsis in comparison to 'stress dose' hydrocortisone administration in adrenal insufficiency (2015) (1)
FAILURE OF P1NP SUPPRESSION FOLLOWING INTRAVENOUS ZOLEDRONATE: EFFECT OF DEFINITIONS, DOSE, VITAMIN D STATUS, AND BMI (2009) (1)
Inheritance in autoimmune addisons: the extended family profile (2007) (1)
Serum Deoxycholic Acid (DCA), Measured by Gas Chromatography-Mass Spectrometry (GC-MS), Correlates with Large Bowel Transit Time (LBTT) (1996) (1)
Pharmacological Control of Post Prandial Plasma Somatostatin in Man (1983) (1)
Anatomy and physiology of the thyroid (2009) (1)
Nonfunctioning and Gonadotrophin-Secreting Adenomas (2017) (1)
Syndromes of hormone resistance (2009) (1)
Evaluation of acromegaly status following surgery by OGTT, GH day curve and IGF-I: relationships between these parameters (2007) (1)
Hypopituitarism following Russell's Viper bite: a case report (2010) (1)
Diagnostic and therapeutic outcome in ERCUSYN: Preliminary report in over 1000 patients (2014) (1)
Adrenal emergency is a regular event for treated Addison's patients (2008) (1)
Quality of life in patients with non-functioning pituitary adenomas (2014) (1)
122 Cardiac Abnormalities are Common in Patients Diagnosed with Phaeochromocytoma as Detected by Cardiovascular Magnetic Resonance Imaging (2014) (1)
Developing a specialist obesity infrastructure: an example from current strategies in England (2013) (1)
Visual field improvement induced by bromocriptine treatment. (1987) (1)
Clinical experience of Nebido: monitoring the efficacy and safety of intramuscular testosterone undecanoate in hypogonadal men (2008) (1)
Phaeochromocytomas and paragangliomas (2009) (1)
Acute falciparum malaria and parathyroid function (2007) (1)
Treatment With Gonadotrophin Releasing Hormone Analogue in Advanced Prostatic Cancer (1983) (1)
Shaping academic medicine (2014) (1)
Diabetic renal disease (2009) (1)
Pituitary apoplexy: diagnosis and management (2014) (1)
Osteoclast formation from circulating precursors in primary and secondary osteoporosis. (2000) (1)
A survey of dopamine agonist withdrawal policy in UK endocrinologists treating patients with prolactinomas. Clinical Endocrinology 58, 111 (2003) (1)
History of Prolactin Disorders (2019) (1)
Epidemiology of Addison's disease in the area of banbury, oxfordshire (2011) (1)
AIP immunostaining is increased with lanreotide therapy in individuals with acromegaly and predicts changes in IGF-1 levels in female patients (2009) (1)
Management of cranial Diabetes Insipidus - clinical outcomes and patient perception of care. (2022) (1)
13.9 Organization of diabetes care (2011) (1)
Turner's syndrome: what are the issues? (2002) (1)
Multi-parametric cardiovascular magnetic resonance imaging detects subclinical myocardial involvement in patients diagnosed with phaeochromocytoma (2015) (1)
ENHANCING HYPOTHALAMIC LESIONS SHOWN ON HIGH RESOLUTION COMPUTERIZED TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM (1986) (1)
Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly. (1983) (1)
Serial imaging in macroprolactinomas: for how long? (2009) (1)
Pegvisomant: a new treatment modality for acromegaly. (2004) (1)
GASTROINTESTINAL BLEEDING IN PATIENTS ON BROMOCRIPTINE (1976) (1)
Recurrence rates in patients with non-functioning pituitary adenomas presenting with acute apoplexy: a long-term follow-up study (2010) (1)
University of Birmingham Epidemiology of Acromegaly: Review of population studies (2016) (0)
The role of an endocrine specialist nurse in a nurse led testosterone implant clinic (2007) (0)
Inherited disorders of bone (2009) (0)
Mastocytosis: A Differential Diagnosis of Flushing (1998) (0)
170 NON-GH DEPENDENT INSUL IN-LIKE GROWTH FACTOR BINDING PROTEIN (IGF-BP) PROF ILES IN DIABETIC ADOLESCENTS (1988) (0)
11.1 Secondary endocrine tumours, ectopic hormone syndromes, and effects of cancer treatment on endocrine function (2011) (0)
McCune–Albright syndrome (2009) (0)
Long-term morbidities in patients with Cushing's disease (2010) (0)
The new biology of pituitary natriuretic peptides: novel signalling from guanylyl cyclase-B receptors (2008) (0)
13.2 Aetiology and pathogenesis of type 1 diabetes mellitus (2011) (0)
13.5 Microvascular complications (2011) (0)
Adrenal incidentaloma: how frequently do adrenal incidentalomas cause problems in terms of hormone hypersecretion or tumour growth? (2011) (0)
Nebido (testosterone undecanoate) in patients over 60 years of age: a time to reduce dose frequency? (2011) (0)
Predictors of recurrence in Graves' disease in Oxford (2008) (0)
(PREMIER POSTER - AWARD CANDIDATE) TREATMENT GUIDANCE IN WOMEN WITH WRIST FRACTURE: NICE TA161, NOGG AND FRAX (2009) (0)
Combined use of vasopressin and synthetic hypothalamic releasing factors as test of anterior pituitary function (1986) (0)
The argument for growth hormone day curve testing in acromegaly; significant discrepancy between mean growth hormone and random growth hormone levels (2019) (0)
Antiangiogenic effect of lanreotide on GH-secreting pituitary adenomas (2002) (0)
7.2 Growth and sexual disorders in childhood (2011) (0)
Use of IT in diabetes Care (2010) (0)
Testogel - An effective and acceptable androgen replacement (2005) (0)
Syndrome of inappropriate ADH (SIADH) (2009) (0)
A study of acromegaly-associated headache with somatostatin analgesia. (2023) (0)
12.2 Lipoprotein metabolism and related diseases (2011) (0)
Optimal timing of thyroxine dose adjustment for treating patients with primary hypothyroidism: what is the estimated time required to reach stable TSH levels? (2012) (0)
Imaging of the pituitary is indicated in marginal hyperprolactinaemia (lt1000 milliunits per litre) to detect microadenoma (2004) (0)
Hypochlorhydria Reduces Plasma Somatostatin Response to Food (1982) (0)
Abbreviated metyrapone day curves: do they work? (2008) (0)
Gastric adenocarcinoma and ectopic ACTH syndrome (2007) (0)
Quality of life in patients with non-functioning pituitary adenoma: the Oxford experience (2012) (0)
Simplifying Drug Discovery with JMP (2010) (0)
What is the natural history of scalp hairloss in association with the use of somatostatin analogues in the treatment of acromegaly (2002) (0)
13.3 Disorders of the posterior pituitary gland (2010) (0)
[Excretion of fluorine by the kidney during chronic kidney failure and after transplantation]. (1974) (0)
Practice Guideline Diagnosis and Treatment of Hyperprolactinemia : An Endocrine Society Clinical (2011) (0)
2.6 Neuropsychiatric endocrinological disorders (2011) (0)
The effect of pituitary surgery on VEGF, MMP 2 and MMP 9 levels in acromegaly and non-functioning pituitary adenomas (2010) (0)
Comorbidities are the norm for steroid-dependent patients and predispose to adrenal crisis (2015) (0)
Endocrinology aspects of other clinical or physiological situations (2014) (0)
Associated health conditions and occupational status are risk factors for adrenal crisis in treated Addison's disease (2009) (0)
Faculty Opinions recommendation of Subclinical thyrotoxicosis in an outpatient population - predictors of outcome. (2011) (0)
Renal tubular abnormalities (2009) (0)
Faculty Opinions recommendation of Effect of selective serotonin reuptake inhibitors on the risk of fracture. (2007) (0)
Assessment of the feasibility of early hospital discharge following trans-sphenoidal pituitary surgery (2011) (0)
Lipids and hyperlipidaemia (2014) (0)
Hormone Replacement Therapy and Cardiovascular Disease in Women (2002) (0)
Endocrine and diabetes nursing (2009) (0)
Prolonged remission of acromegaly after cessation of somatostatin analogue treatment (2010) (0)
Pitfalls in laboratory endocrinology (2009) (0)
Session III. Growth related growth factors : Variations in the small insulin-like growth factor binding protein, sex hormone binding globulin and insulin with pubertal development (1990) (0)
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus (2022) (0)
Cushing's syndrome or is it? a case report (2008) (0)
Thromboembolism in patients with Cushing's disease - a retrospective case review (2002) (0)
Unemployment and return to work after the diagnosis of a chronic endocrine condition (2010) (0)
Response to Letter to the Editor from Chee et al: “Prevention of Adrenal Crisis: Cortisol Response to Major Stress Compared to Stress Dose Hydrocortisone Delivery” (2020) (0)
The use of a specific questionnaire to assess quality of life in growth hormone deficient adults (2003) (0)
Letter: Dopamine and inhibition of prolactin and growth-hormone secretion. (1976) (0)
University of Birmingham Pheochromocytoma is Characterized By Catecholamine Myocarditis, Focal and Diffuse Fibrosis, and Persistent Subclinical Systolic and Diastolic Dysfunction (2016) (0)
Hormone Replacement Therapy with Testosterone (2002) (0)
(PREMIER POSTER - AWARD CANDIDATE) FREQUENCY AND PREDICTORS OF VITAMIN D STATUS IN POST-MENOPAUSAL WOMEN PRESENTING WITH A FRAGILITY FRACTURE OF THE DISTAL RADIUS (2009) (0)
Anatomy and physiology of anterior pituitary gland (2009) (0)
Diabetes and Endocrinology (2020) (0)
Part 10 Endocrinology of ageing and systemic disease (2011) (0)
Somatostatinoma (2021) (0)
Examination of the Thyroid Gland and Thyroid Status (2007) (0)
13.4.3 Diabetes in diverse ethnic groups (2011) (0)
Adrenal disorders during pregnancy (2009) (0)
Complications of testosterone replacement in men with primary and secondary hypogonadism (2003) (0)
INSULIN-DEPENDENCE OF THE SMALL IGF-BINDING PROTEIN (IGF-SBP) (1989) (0)
Control of GH and IGF1 in acromegaly in the UK: responses to medical treatment (2012) (0)
3.1 Evaluation of the thyroid patient (2011) (0)
12.1 Epidemiology, aetiology, and management of obesity (2011) (0)
Endocrinology in pregnancy (2014) (0)
Prospective assessment of pituitary function in patients with macroprolactinoma treated with cabergoline (2011) (0)
12.3 Other metabolic disorders (2011) (0)
Somatotroph adenoma subtype and responsiveness to somatostatin analogues in patients with acromegaly (2010) (0)
Multinodular goitre and solitary adenomas (2009) (0)
Editorial (1991) (0)
Unexplained severe hypoglycaemia in hospital: a difficult diagnostic challenge. (2009) (0)
The effect of lanreotide therapy on gallbladder emptying in patients with acromegaly (1998) (0)
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease of bone (1999) (0)
13.4.9 Non-biological technologies in glucose sensing (2011) (0)
Amiodarone and thyroid function (2009) (0)
Alternative or complementary therapy and endocrinology (2009) (0)
O-053. Acromegaly, colonic polyps and carcinoma (1997) (0)
SUN-LB48 Increased Mortality in Acromegaly Is Mainly Due to Vascular and Respiratory Disease and Is Normalized by Control of Growth Hormone Hypersecretion (2020) (0)
7.1 Normal growth and sexual development (2011) (0)
Voluntary support for pituitary patients (1994) (0)
Polycystic ovary syndrome (PCOS) (2009) (0)
Pheochromocytoma is Characterized By Catecholamine Myocarditis, Focal and Diffuse Fibrosis, and Persistent Subclinical Systolic and Diastolic Dysfunction (2016) (0)
Society for Endocrinology Jubilee Medal Lecture (2009) (0)
How reliable is the short Synacthen test in assessing the integrity of the hypothalamo-pituitary-adrenal axis: comparison with the insulin tolerance test (2008) (0)
Quick Reference Material (2009) (0)
Do symptoms and signs of acromegaly correlate with GH during medical treatment (2002) (0)
13.8 Mental health and diabetes mellitus (2011) (0)
The value of the anti-thyroid peroxidase antibodies measurement in the diagnosis of Graves' disease (2008) (0)
Functional Properties of Naturally Occurring Insulin Receptor Mutations (1995) (0)
Octreotide (2021) (0)
2.3 Aetiology, pathogenesis, and management of disease of the pituitary (2011) (0)
Actual and Potential Clinical Uses of IGF-1 (1993) (0)
Densely and sparsely granulated somatotroph adenomas: clinical, genetic and histological differences (2013) (0)
Endocrine Investigation Series (1994) (0)
High incidence of cardiac involvement in patients diagnosed with phaeochromocytoma: a clinical study using cardiovascular magnetic resonance imaging (2014) (0)
Mortality of patients with non-functioning pituitary macroadenoma is significantly elevated: systematic analysis of 546 cases in a tertiary referral centre in the UK (2015) (0)
Testogel - Improves well being and libido in hypogonadal men (2005) (0)
Part 6 Neuroendocrine tumours and genetic disorders (2011) (0)
Surgical treatment of pituitary tumours (2009) (0)
Craniopharyngiomas and perisellar cysts (2009) (0)
Adrenal Cushing's syndrome (2009) (0)
Faculty of 1000 evaluation for Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma (2012) (0)
A thyroid nurse-led service: patients' perspective: an audit (2009) (0)
Does skin thickness affect the absorption of Testogel (2009) (0)
Disorders of the posterior pituitary gland (2020) (0)
Stress and the endocrine system (2009) (0)
Part 2 Pituitary and hypothalamic diseases (2011) (0)
Editorial (1994) (0)
Menin-mutation negative MEN1-syndrome patients have no germline p27 (cyclin-dependent kinase inhibitor 1B) or AIP (aryl hydrocarbon receptor-interacting protein) mutations (2008) (0)
9.3 Evaluation of the male patient with suspected hypogonadism and/or infertility (2011) (0)
The importance of a specialized adult Turner Syndrome clinic (2009) (0)
Part 3 The thyroid (2011) (0)
An endocrine e-mail GP advisory service: a potential way to reduce referrals? (2008) (0)
The use of combined GHRH and arginine test in the diagnosis of growth hormone deficiency in successfully treated acromegalics (2003) (0)
Endocrinology of critical illness (2009) (0)
The Prevention of Octreotide-Induced Gallstones—Does Cisapride Overcome the Effects of Octreotide on Gallbladder Emptying? (1997) (0)
POLYMORPHISMS OF THE TRANSFORMING GROWTH FACTOR beta GENE ARE ASSOCIATED WITH BONE MASS AND INFANT GROWTH IN UK MEN BUT NOT WOMEN (2004) (0)
The treatment of acromegaly. (1986) (0)
Proceedings: The excretion of fluoride by the kidney during chronic renal failure and following transplantation. (1974) (0)
Expression of guanylyl cyclase-B (GC-B) receptors in a range of human pituitary adenomas: evidence for a local natriuretic peptide system (2009) (0)
Rathke's cleft cysts in need of regular follow-up in case of recurrence (2010) (0)
Androgen replacement therapy (2009) (0)
Severe adverse event after use of IV zoledronate in a patient with mastocytosis: A case report (2009) (0)
Low rate of recurrence after excision of non-familial phaeochromocytomas (2011) (0)
2.4 Aetiology, pathogenesis, and management of diseases of the hypothalamus (2011) (0)
The high dose dexamethasone suppression test is dead (2009) (0)
Menstrual function disorders—assessment and investigation (2009) (0)
3.4 Hypothyroidism and pregnancy- and growth-related thyroid disorders (2011) (0)
Inhibition of cell proliferation, but lack of antiangiogenic effect on GH-secreting pituitary adenomas treated with Lanreotide (2004) (0)
Diagnostic and financial benefits of checking TSH receptor antibodies in patients with thyrotoxicosis (2010) (0)
13.3 Aetiology and pathogenesis of type 2 diabetes mellitus (2011) (0)
11.2 Hormonal therapy for breast and prostatic cancers (2011) (0)
3.3 Thyrotoxicosis and related disorders (2011) (0)
Management of dyslipidaemia (2009) (0)
Comprar Plastic Forming Processes | Ian D. Hay | 9781848210660 | Wiley (2009) (0)
Specimen integrity and statistics: two essential components of good veterinary practice. (2009) (0)
Symptomatic Rathke cleft cysts: systematic review of 10 cases with long follow-up (2005) (0)
Pituitary function—dynamic tests (2009) (0)
Should your lab perform tumor immunology? (1990) (0)
Should we take macroprolactinoma patients off dopamine agonists at 3 or 5 years as they almost invariably recur (2010) (0)
Factors affecting insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults (2002) (0)
Role of intestinal transit and DCA (1997) (0)
Thyroid nurse-led clinic service: a positive healthcare initiative (2009) (0)
The Therapeutic Modulation of Growth Hormone Release (1989) (0)
Hyperandrogenism, Polycystic Ovarian Disease (2002) (0)
Section Introduction: Acute Medical Care – A Crisis with Solutions (2014) (0)
Anterior pituitary hormone replacement (2009) (0)
The UK pituitary register Collecting data for acromegaly (1999) (0)
Investigation of calcium, phosphate, and magnesium (2009) (0)
Growth hormone replacement: Patients' views (2002) (0)
Systemetic dose extension of octreotide LAR - the importance of individual tailoring of treatment (2004) (0)
Long term morbidities in a large series of patients with Cushing's disease (2011) (0)
Classification and diagnosis (2009) (0)
pound31,474 saved with shared care (2002) (0)
Problem-based review: The patient with acute adrenal failure. (2013) (0)
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. (2022) (0)
Steroid Replacement Education: Impact on Patients and their Carers (2011) (0)
Part 5 The adrenal gland and endocrine hypertension (2011) (0)
Disorders of sexual differentiation (2009) (0)
Emergencies in diabetes (2009) (0)
Does the degree of tumour shrinkage by pre-operative treatment with lanreotide affect the surgical success in acromegaly caused by pituitary macroadenoma? (2007) (0)
How useful is IGF-I in adults with GH deficiency? (2005) (0)
AIP and familial acromegaly (2007) (0)
Growth of Three Established Cell Lies on Glass Micmders (1983) (0)
Von Hippel–Lindau disease (2009) (0)
The use of steroid replacement therapy for the management of Addison's disease. (1999) (0)
Ghrelin is reduced in women with polycystic ovary syndrome and correlates inversely with HOMA IR and testosterone (2007) (0)
Part 9 Male hypogonadism and infertility (2011) (0)
Androgen-secreting tumours (2009) (0)
Pituitary tumours: recommendations for service provision and guidelines for management of patients. Committee on Endocrinology of the Royal College of Physicians and the Society for Endocrinology, and the Research Unit of the Royal College of Physicians. (1998) (0)
Association of the thyrotrophin receptor gene (TSHR) with Gravesapos disease: evidence from independent UK population based case control and family studies (2005) (0)
A review of the Endocrine Transition Service over the last 10 years (2011) (0)
Does GH replacement increase the risk of recurrence in patients with craniopharyngioma (2005) (0)
Product Development and Applied Research : A Formalized Approach Using SAS ® and JMP ® (2000) (0)
Session V. Critical growth periods : interrelationships between growth hormone, insulin, insulin-like growth factor I and insulin binding protein I in acromegaly (1990) (0)
Increased angiogenesis but not lymphangiogenesis in parathyroid proliferative lesions: A possible role for FGF-2 (2003) (0)
Hormonal manifestations of nonendocrine disease (2010) (0)
Do non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than other non-functioning adenomas? (2002) (0)
Growth and stature (2009) (0)
Part 12 Obesity, lipids, and metabolic disorders (2011) (0)
Introduction (2009) (0)
13.10 Transplantation in Diabetes (2011) (0)
Part 7 Growth and development during childhood (2011) (0)
In search of the genetic basis of polycystic ovary syndrome and its metabolic consequences (2009) (0)
Epidemiology of pituitary adenomas: a cross-sectional study in the city of Banbury (Oxfordshire) (2008) (0)
13.4.10 Management of diabetes mellitus in special situations (2011) (0)
Parasellar inflammatory conditions (2009) (0)
Phrenic Nerve Terminal Motor Latency in Hyperthyroidism (1987) (0)
Validity of the new pituitary apoplexy guideline group scoring system (PAGGS) in the management of pituitary apoplexy: a large retrospective review of 46 patients with classical pituitary apoplexy (2010) (0)
The Prevention of Adrenal Crisis in Stress (PACS) study: serum cortisol during elective surgery and acute trauma in comparison to stress dose hydrocortisone in adrenal insufficiency (2014) (0)
9.5 Exogenous factors and male reproductive health (2011) (0)
Inherited primary hyperparathyroidism (2009) (0)
Lanreotide (Somatuline Autogel) causes marked tumour shrinkage in a case of gigantism (2007) (0)
The clinical and genetic characteristics of patients with familial isolated pituitary adenoma (2009) (0)
Part 13 Diabetes mellitus (2011) (0)
Do diabetes trainees have an appetite for bariatric medicine? (2015) (0)
Editorial (1991) (0)
Faculty Opinions recommendation of Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism. (2009) (0)
Cell Biology International Reports, Vol. 5, No. 5, May 1987 Chemotactic Factor-Induced Adherence of Tumor Cells (2003) (0)
9.4 Male endocrinological disorders and male factor infertility (2011) (0)
General management and treatment (2009) (0)
Patient support groups and other endocrine organizations (2009) (0)
Lymphocytic hypophysitis: What is the long-term outcome? (2005) (0)
Guidelines for getting into the veterinary market. (1988) (0)
Pituitary function and vision following surgical intervention for suprasellar meningiomas (2008) (0)
Improving communication in clinical care: a re-audit of an Endocrinology and Diabetes GP e-mail advisory service following commissioning (2011) (0)
Intercurrent events or disease (2009) (0)
What's new in... Endocrinology (2001) (0)
Clinical Focus - Thyrotoxicosis (2009) (0)
Liothyronine prescribing in the UK has changed dramatically with widespread variation by clinical commissioning group and is strongly influenced by economic deprivation (2018) (0)
Diabetes insipidus (DI) (2009) (0)
Getting it right first time for endocrinology (2019) (0)
Inherited renal calculi (2009) (0)
Magnetic resonance perfusion enables assessment of blood supply to pituitary gland (2002) (0)
Perioperative management of endocrine patients (2009) (0)
LETTER TO THE EDITORS (1987) (0)
Long-term glucocorticoid administration (2009) (0)
9.2 Normal male endocrinology (2011) (0)
Subject Index Vol. 71, Suppl. 1, 2009 (2009) (0)
Part 8 Female endocrinology and pregnancy (2011) (0)
Premature ovarian failure (POF) (2009) (0)
Response to Letter to the Editor: “Prevention of Adrenal Crisis: Cortisol Response to Major Stress Compared to Stress Dose Hydrocortisone Delivery” (2020) (0)
3.5 Thyroid lumps (2011) (0)
Increased risk of infections in Addison's disease and congenital adrenal hyperplasia patients: a longitudinal study based on a United Kingdom primary care database (2019) (0)
Comprar Clinical Endocrine Oncology | John Wass | 9781405145848 | Blackwell Publishing (2008) (0)
Long acting somatostatin analogues administered by practice nurses: an audit (2004) (0)
An interesting case of Turner syndrome with spontaneous pregnancies (2009) (0)
Clinical experience of Nebido: monitoring the efficacy and safety of testosterone undecanoate in men over 60 years of age (2010) (0)
Pituitary apoplexy new society guidelines for treatment (2011) (0)
Part 4 Parathyroid, calcium, and bone metabolism (2011) (0)
Regional variations in colonic neoplasia in acromegaly (2004) (0)
8.2 Pregnancy-related disorders (2011) (0)
Ectopic ACTH syndrome: experience of a tertiary referral centre: from diagnosis to outcome (2011) (0)
8.1 Female endocrinology and ovarian disorders (2011) (0)
3.2 Aetiology of thyroid disorders (2011) (0)
Testosterone replacement therapy isn't always contraindicated after prostate cancer treatment: case report (2010) (0)
Non-functioning pituitary tumours (2009) (0)
The Effects of Maternal Endocrine Disease on the Fetus and Neonate (1984) (0)
FATIGUE AND OTHER SYMPTOMS FOLLOWING INTRAVENOUS ZOLEDRONATE THERAPY (2009) (0)
Part 11 Endocrinology of cancer (2011) (0)
Calcium and bone physiology (2009) (0)
Weekly thyroxine administration: a safe method to administer thyroxine when compliance issues arise (2007) (0)
Cushing's disease and coexistent craniopharyngioma - report of a case (2004) (0)
Subject Index, Vol. 54, Supplement 1, 1993 (1993) (0)
Excess other mineralocorticoids (2009) (0)
13.6 Macrovascular diseases and diabetes mellitus (2011) (0)
The acute octreotide suppression test is useful in predicting long-term responses to depot somatostatin analogue injections in patients with active acromegaly (2004) (0)
Expanding boundaries of endocrinology. (2010) (0)
Whole-exome sequencing studies of non-functioning pituitary adenomas (2013) (0)
Octreotide LAR - a patient and nurse perspective (2003) (0)
Rickets and osteomalacia (2009) (0)
Cushing's disease (2009) (0)
Hypercalcaemia in acromegaly is not always due to MEN-1 (2005) (0)
A novel mechanism of effect for somatostatin analogues: the role of AIP (2010) (0)
Drug treatment of pituitary tumours (2009) (0)
Paget's disease (2009) (0)
JCEM ARCHIVEDiagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline (2011) (0)
Gall stones induced by octreotide. (1992) (0)
Addison’s disease (2009) (0)
Changes in fluorescence capping of tumor cells upon response to a chemotactic peptide (1981) (0)
Graves' ophthalmopathy, dermopathy, and acropachy (2009) (0)
Part 1 Principles of international endocrine practice (2011) (0)
Social and practical aspects (2009) (0)
Inherited endocrine syndromes and MEN (2014) (0)
Post-operative Replacement and Assessment of HPA Axis Recovery in Cushing’s Syndrome (2010) (0)
10.1 Ageing and the endocrine system (2011) (0)
Clinical and scientifi c letters (2015) (0)
An analysis of the dose of levothyroxine in patients with central hypothyroidism (2009) (0)
10.2 Endocrinology of systemic disease (2011) (0)
The neuroendocrine system (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John A. H. Wass?

John A. H. Wass is affiliated with the following schools:

University of Oxford

John A. H. Wass's Academic­Influence.com Rankings

Why Is John A. H. Wass Influential?

John A. H. Wass's Published Works

Published Works

What Schools Are Affiliated With John A. H. Wass?

John A. H. Wass's AcademicInfluence.com Rankings